Effect	effect	O	O
of	of	O	O
alpha-tocopherol	alpha-tocopherol	O	O
and	and	O	O
deferoxamine	deferoxamine	S_chemical	O
on	on	O	O
methamphetamine-induced	methamphetamine-induced	O	O
neurotoxicity	neurotoxicity	O	S_disease
.	.	O	O

Methamphetamine	methamphetamine	S_chemical	O
(MA)-induced	(ma)-induced	O	O
dopaminergic	dopaminergic	O	O
neurotoxicity	neurotoxicity	O	S_disease
is	is	O	O
believed	believed	O	O
to	to	O	O
be	be	O	O
associated	associated	O	O
with	with	O	O
the	the	O	O
increased	increased	O	O
formation	formation	O	O
of	of	O	O
free	free	B_chemical	O
radicals	radicals	I_chemical	O
.	.	O	O

This	this	O	O
study	study	O	O
examined	examined	O	O
the	the	O	O
effect	effect	O	O
of	of	O	O
alpha-tocopherol	alpha-tocopherol	O	O
(	(	O	O
alpha-TC	alpha-tc	O	O
)	)	O	O
,	,	O	O
a	a	O	O
scavenger	scavenger	O	O
of	of	O	O
reactive	reactive	B_chemical	O
oxygen	oxygen	S_chemical	O
species	species	I_chemical	O
,	,	O	O
and	and	O	O
deferoxamine	deferoxamine	S_chemical	O
(	(	O	O
DFO	dfo	S_chemical	O
)	)	O	O
,	,	O	O
an	an	O	O
iron	iron	S_chemical	O
chelator	chelator	O	O
,	,	O	O
on	on	O	O
the	the	O	O
MA-induced	ma-induced	O	O
neurotoxicity	neurotoxicity	O	S_disease
.	.	O	O

Male	male	O	O
rats	rats	O	O
were	were	O	O
treated	treated	O	O
with	with	O	O
MA	ma	O	O
(	(	O	O
10	10	O	O
mg/kg	mg/kg	O	O
,	,	O	O
every	every	O	O
2	2	O	O
h	h	S_chemical	O
for	for	O	O
four	four	O	O
injections	injections	O	O
)	)	O	O
.	.	O	O

The	the	O	O
rat	rat	O	O
received	received	O	O
either	either	O	O
alpha-TC	alpha-tc	O	O
(	(	O	O
20	20	O	O
mg/kg	mg/kg	O	O
)	)	O	O
intraperitoneally	intraperitoneally	O	O
for	for	O	O
3	3	O	O
days	days	O	O
and	and	O	O
30	30	O	O
min	min	O	O
prior	prior	O	O
to	to	O	O
MA	ma	O	O
administration	administration	O	O
or	or	O	O
DFO	dfo	S_chemical	O
(	(	O	O
50	50	O	O
mg/kg	mg/kg	O	O
)	)	O	O
subcutaneously	subcutaneously	O	O
30	30	O	O
min	min	O	O
before	before	O	O
MA	ma	O	O
administration	administration	O	O
.	.	O	O

The	the	O	O
concentrations	concentrations	O	O
of	of	O	O
dopamine	dopamine	S_chemical	O
(	(	O	O
DA	da	S_chemical	O
)	)	O	O
,	,	O	O
serotonin	serotonin	S_chemical	O
and	and	O	O
their	their	O	O
metabolites	metabolites	O	O
decreased	decreased	O	O
significantly	significantly	O	O
after	after	O	O
MA	ma	O	O
administration	administration	O	O
,	,	O	O
which	which	O	O
was	was	O	O
inhibited	inhibited	O	O
by	by	O	O
the	the	O	O
alpha-TC	alpha-tc	O	O
and	and	O	O
DFO	dfo	S_chemical	O
pretreatment	pretreatment	O	O
.	.	O	O

alpha-TC	alpha-tc	O	O
and	and	O	O
DFO	dfo	S_chemical	O
attenuated	attenuated	O	O
the	the	O	O
MA-induced	ma-induced	O	O
hyperthermia	hyperthermia	O	S_disease
as	as	O	O
well	well	O	O
as	as	O	O
the	the	O	O
alterations	alterations	O	O
in	in	O	O
the	the	O	O
locomotor	locomotor	O	O
activity	activity	O	O
.	.	O	O

The	the	O	O
level	level	O	O
of	of	O	O
lipid	lipid	O	O
peroxidation	peroxidation	O	O
was	was	O	O
higher	higher	O	O
and	and	O	O
the	the	O	O
reduced	reduced	O	O
glutathione	glutathione	S_chemical	O
concentration	concentration	O	O
was	was	O	O
lower	lower	O	O
in	in	O	O
the	the	O	O
MA-treated	ma-treated	O	O
rats	rats	O	O
.	.	O	O

These	these	O	O
changes	changes	O	O
were	were	O	O
significantly	significantly	O	O
attenuated	attenuated	O	O
by	by	O	O
alpha-TC	alpha-tc	O	O
and	and	O	O
DFO	dfo	S_chemical	O
.	.	O	O

This	this	O	O
suggests	suggests	O	O
that	that	O	O
alpha-TC	alpha-tc	O	O
and	and	O	O
DFO	dfo	S_chemical	O
ameliorate	ameliorate	O	O
the	the	O	O
MA-induced	ma-induced	O	O
neuronal	neuronal	O	B_disease
damage	damage	O	I_disease
by	by	O	O
decreasing	decreasing	O	O
the	the	O	O
level	level	O	O
of	of	O	O
oxidative	oxidative	O	O
stress	stress	O	O
.	.	O	O

